medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2006, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2006; 53 (2)

Development of antisera to identify M-1 and M-3 Streptococcus pyogenes strain serotypes associated to severe invasive infections

Márquez-Rosales MG, Villaseñor-Sierra A

Language: Spanish
References: 17
Page: 93-99
PDF size: 106.97 Kb.


ABSTRACT

Introduction: Development of antisera to identify M-1 and M-3 S. pyogenes strain serotypes is important to identify those isolated from patients with severe invasive infections in Mexico. Methods: New Zealand rabbits were immunized with M-1 and M-3 S. pyogenes strains. The immune sera was adsorbed with heterologous serotypes and challenged against homologous and heterologous strains (B3264, M-non-typeable, M-4, M-6 and M-12) using capillary precipitation test, double diffusion Ouchterlony test or indirect bactericidal test to evaluate serotype specificity and bactericidal activity. Results: The micro precipitin capillary test showed high level titers of serotype specific antibodies. The bactericidal activity of antisera against homologous strains was elevated, but absent with heterologous strains. The double diffusion Outcherlony test first showed a double band of precipitation with the homologous antiserum, which was then reduced to a single band when antisera was adsorbed against a heterologous serotype. There was no cross-reactive activity of antisera against heterologous strains and the potency was high. Conclusions: The animal model was successful for obtaining serotype specific antisera against M-1 and M-3 serotypes, without cross-reactions against other serotypes, and was also highly potent. It will be useful for identifying S. pyogenes serotypes associated with severe infections in our country.


REFERENCES

  1. Floyd WD Jr. History of hemolytic streptococci and associated diseases. In: Stevens DL, Kaplan EL, eds. New York, NY: Oxford University Press, 2000: 1-18.

  2. Stevens DL. Group A beta-hemolytic streptococci: Virulence factors, pathogenesis, and spectrum of clinical infections. In: Stevens DL, Kaplan EL, eds. New York, NY: Oxford University Press, 2000: 19-36.

  3. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Micro 1991; 29 (8):1562-1567.

  4. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374-382.

  5. Kohler W, Gerlach D, Knoll H. Streptococcal outbreaks and erythrogenic toxin type A. Zentralbl Bakteriol Mikrobiol Hyg 1987; 266: 104-115.

  6. Mollick JA, Rich RR. Characterization of a superantigen from a pathogenic strain of Streptococcus pyogenes. Clin Res 1991; 39 (2): 213A.

  7. Quiñonez-Alvarado MG, Villasenor-Sierra A. Métodos convencionales y moleculares para la identificación y tipificación de Streptococcus pyogenes. Enfermedades Infecciosas y Microbiología 2004: 84-88.

  8. Characterization of group A streptococci. In: Stevens DL, Kaplan EL eds. New York, NY: Oxford University Press, 1996: 33-36.

  9. Villasenor-Sierra A, Santos-Preciado JI. Síndrome de choque tóxico por estreptococo beta hemolítico del grupo A: criterios diagnósticos. Gac Med Mex 1999; 135: 205-207.

  10. Especificaciones técnicas para la producción, cuidado y uso de animales de laboratorio (PROY-NOM-SSA062-ZOO-1999). 1999.

  11. Production of antisera for serological grouping and serotyping. In: Johnson DR, Kaplan EL, Sramek J et al eds. Minneapolis, MN, USA: World Health Organization, 1996: 96-104.

  12. Lancefield RC. Type-specific antigens, M and T, of Matt and Glossy variants of group A hemolytic streptococci. J Exp Med 1940; 71: 521-537.

  13. Todd EW. Method of measuring increase or decrease of population of haemolytic streptococci in blood. Brit J Exper Path 1927; 8: 1-5.

  14. Lancefield RC. Differentiation of group A streptococci with a common R antigen into three serologycal types with a special reference to the bactericidal test. J Exp Med 1957; 106: 525-544.

  15. Stollerman GH, Kantor FS, Gordon BD. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. J Exp Med 1958; 108: 475-491.

  16. Lancefield RC. The antigenic complex of Streptococcus haemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus. J Exp Med 1928; 47: 91-103.

  17. Lancefield RC. A micro precipitin-technic for classifying hemolytic streptococci, and improved methods for producing antisera. Proc Soc Exp Biol Med 1938; 38: 473-478.




2020     |     www.medigraphic.com